Anne FOGLI
Maitre de Conférences - Praticien Hospitalie
FOGLI
Anne
Maitre de Conférences - Praticien Hospitalie
MCU-PH
Publications
The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation.
Published on 25 Apr 2022 in International journal of molecular sciences , vol. 23
Le Boiteux E , Guichet PO, Masliantsev K, Montibus B , Vaurs-Barriere C, Gonthier-Gueret C, Chautard E, Verrelle P, Karayan-Tapon L, Fogli A , Court F , Arnaud P
Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.
Published on 30 Aug 2021 in Molecular oncology , vol. 15 - pp 1995-2010
Le Boiteux E , Court F , Guichet PO, Vaurs-Barrière C , Vaillant I , Chautard E, Verrelle P, Costa BM, Karayan-Tapon L, Fogli A , Arnaud P
Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.
Published on 07 Dec 2020 in PLoS biology , vol. 18 - pp e3000948
Bousset L , Septier A , Bunay J, Voisin A , Guiton R , Damon-Soubeyrant C, Renaud Y , De Haze A , Sapin V , Fogli A , Rambur A , De Joussineau C , Kocer A , Trousson A , Henry-Berger J , Höring M, Liebisch G, Matysik S, Lobaccaro JA, Morel L , Baron S
Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter.
Published on 04 Apr 2019
Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, van der Knaap MS, Fogli A , Boespflug-Tanguy O, Abbink TEM, Schiffmann R
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
Published on 30 Oct 2019 in Genome research , vol. 29 - pp 1605-1621
Court F , Le Boiteux E , Fogli A , Müller-Barthélémy M, Vaurs-Barrière C , Chautard E, Pereira B, Biau J, Kemeny JL, Khalil T, Karayan-Tapon L, Verrelle P, Arnaud P
The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.
Published on 20 Mar 2018 in Oncotarget , vol. 9 - pp 15740-15756
Xavier-Magalhães A, Gonçalves CS, Fogli A , Lourenço T, Pojo M, Pereira B, Rocha M, Lopes MC, Crespo I, Rebelo O, Tão H, Lima J, Moreira R, Pinto AA, Jones C, Reis RM, Costello JF, Arnaud P , Sousa N, Costa BM
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.
Published on 30 Nov 2017 in Journal of neuro-oncology , vol. 135 - pp 381-390
Fogli A , Demattei MV, Corset L, Vaurs-Barrière C , Chautard E, Biau J, Kémény JL, Godfraind C, Pereira B, Khalil T, Grandin N , Arnaud P , Charbonneau M , Verrelle P
Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive.
Published on 29 Jan 2016 in Nucleic acids research , vol. 44 - pp 621-35
Maupetit-Méhouas S , Montibus B , Nury D , Tayama C, Wassef M, Kota SK, Fogli A , Cerqueira Campos F , Hata K, Feil R, Margueron R, Nakabayashi K, Court F , Arnaud P
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients’ survival.
Published on 01 Mar 2016 in Carcinogenesis , vol. 37 - pp 169-176
Fogli A , Chautard E, Vaurs-Barrière C , Pereira B, Müller-Barthélémy M, Court F , Biau J, Pinto AA, Kémény JL, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P
Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial.
Published on 11 Jul 2014 in Lipids in health and disease , vol. 13 - pp 112
Dutheil F, Walther G, Chapier R, Mnatzaganian G, Lesourd B, Naughton G, Verney J, Fogli A , Sapin V , Duclos M, Vinet A, Obert P, Courteix D, Lac G
A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
Published on 01 Jan 2013 in PloS one , vol. 8 - pp e53958
de Almeida RA, Fogli A , Gaillard M, Scheper GC, Boesflug-Tanguy O, Pavitt GD
Comparison of three methods of diagnosis of plasma unmeasured anions in critically ill patients.
Published on 30 Oct 2013 in Minerva anestesiologica , vol. 79 - pp 1164-72
Lautrette A, Fejjal M, Aithssain A, Phan TN, Caillot N, Fogli A , Souweine B
CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations.
Published on 01 Jan 2012 in PloS one , vol. 7 - pp e42688
Fogli A , Merle C, Roussel V, Schiffmann R, Ughetto S, Theisen M, Boespflug-Tanguy O
Developmental splicing deregulation in leukodystrophies related to EIF2B mutations.
Published on 01 Jan 2012 in PloS one , vol. 7 - pp e38264
Huyghe A, Horzinski L, Hénaut A, Gaillard M, Bertini E, Schiffmann R, Rodriguez D, Dantal Y, Boespflug-Tanguy O, Fogli A
[Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
Published on 30 Nov 2011 in Revue neurologique , vol. 167 - pp 802-11
Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A , Boespflug-Tanguy O, Labauge P
Peptidomics analysis of lymphoblastoid cell lines.
Published on 01 Jan 2010 in Methods in molecular biology (Clifton, N.J.) , vol. 615 - pp 247-57
Fogli A , Bulet P
[Coupling proteinemia and serum protein electrophoresis: evaluation of the capillary technique (Capillarys 2, Sebia), experience from Clermont-Ferrand].
Published on 01 Nov 2010 in Annales de biologie clinique , vol. 68 - pp 657-67
Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.
Published on 19 Oct 2010 in BMC neurology , vol. 10 - pp 94
Horzinski L, Kantor L, Huyghe A, Schiffmann R, Elroy-Stein O, Boespflug-Tanguy O, Fogli A
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
Published on 30 Aug 2009 in Brain : a journal of neurology , vol. 132 - pp 2161-9
Labauge P, Horzinski L, Ayrignac X, Blanc P , Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Sèze J, Fogli A , Boespflug-Tanguy O
Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
Published on 15 Dec 2009 in PloS one , vol. 4 - pp e8318
Horzinski L, Huyghe A, Cardoso MC, Gonthier C , Ouchchane L, Schiffmann R, Blanc P , Boespflug-Tanguy O, Fogli A
Genes involved in leukodystrophies: a glance at glial functions.
Published on 30 May 2008 in Current neurology and neuroscience reports , vol. 8 - pp 217-29
Boespflug-Tanguy O, Labauge P, Fogli A , Vaurs-Barriere C
Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.
Published on 03 Jun 2008 in Neurology , vol. 70 - pp 2226-32
Vanderver A, Hathout Y, Maletkovic J, Gordon ES, Mintz M, Timmons M, Hoffman EP, Horzinski L, Niel F, Fogli A , Boespflug-Tanguy O, Schiffmann R
No evidence for association between the EIF2B5 gene and multiple sclerosis in French families.
Published on 30 May 2008 in Multiple sclerosis (Houndmills, Basingstoke, England) , vol. 14 - pp 573
Fogli A , Barbier C, Cournu-Rebeix I, Babron MC, Clerget-Darpoux F, Fontaine B, Boespflug-Tanguy O
Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
Published on 30 May 2008 in Annals of human genetics , vol. 72 - pp 410-5
Horzinski L, Gonthier C , Rodriguez D, Scherer C, Boespflug-Tanguy O, Fogli A
[Monoclonal IgM interference with immunoturbidimetric determination of ferritin and transferrin].
Published on 01 Nov 2007 in Annales de biologie clinique , vol. 65 - pp 659-62
[CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
Published on 30 Sep 2007 in Revue neurologique , vol. 163 - pp 793-9
Labauge P, Fogli A , Niel F, Rodriguez D, Boespflug-Tanguy O
Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
Published on 24 Jul 2007 in Neurology , vol. 69 - pp 400-2
Passemard S, Gelot A, Fogli A , N'Guyen S, Barnerias C, Niel F, Doummar D, Arbues AS, Mignot C, de Villemeur TB, Ponsot G, Boespflug-Tanguy O, Rodriguez D
The large spectrum of eIF2B-related diseases.
Published on 02 Mar 2006 in Biochemical Society transactions , vol. 34 - pp 22-9
Fogli A , Boespflug-Tanguy O
Peptidomics and proteomics studies of transformed lymphocytes from patients mutated for the eukaryotic initiation factor 2B.
Published on 07 Aug 2006 in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences , vol. 840 - pp 20-8
Fogli A , Malinverni C, Thadikkaran L, Combes P, Perret F, Crettaz D, Tissot JD, Boespflug-Tanguy O, Stöcklin R, Bulet P
Autosomal dominant leukodystrophy and childhood ataxia with central nervous system hypomyelination syndrome.
Published on 30 Oct 2006 in Annals of neurology , vol. 60 - pp 485; author reply 485-6
Labauge P, Gelot A, Fogli A , Boespflug-Tanguy O, Rodriguez D
Dominant form of vanishing white matter-like leukoencephalopathy.
Published on 30 Oct 2005 in Annals of neurology , vol. 58 - pp 634-9
Labauge P, Fogli A , Castelnovo G, Le Bayon A, Horzinski L, Nicoli F, Cozzone P, Pagès M, Briere C, Marty-Double C, Delhaume O, Gelot A, Boespflug-Tanguy O, Rodriguez D
Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Published on 30 Jul 2004 in European journal of human genetics : EJHG , vol. 12 - pp 561-6
Fogli A , Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O
The effect of genotype on the natural history of eIF2B-related leukodystrophies.
Published on 11 May 2004 in Neurology , vol. 62 - pp 1509-17
Fogli A , Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O
Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure.
Published on 26 Oct 2004 in BMC women's health , vol. 4 - pp 8
Fogli A , Gauthier-Barichard F, Schiffmann R, Vanderhoof VH, Bakalov VK, Nelson LM, Boespflug-Tanguy O
Ovarian failure related to eukaryotic initiation factor 2B mutations.
Published on 30 Jun 2003 in American journal of human genetics , vol. 72 - pp 1544-50
Fogli A , Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O
[eIF2B and Cree Indian leukodystrophies].
Published on 30 Mar 2003 in Medecine sciences : M/S , vol. 19 - pp 283-4
Fogli A , Rodriguez D, Eymard-Pierre E, Boespflug-Tanguy O
Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
Published on 30 Oct 2002 in Annals of neurology , vol. 52 - pp 506-10
Fogli A , Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R
A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
Published on 24 Dec 2002 in Neurology , vol. 59 - pp 1966-8
Fogli A , Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E
